2025-10-27T08:27:25-05:00 2024-12-31 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2024-01-01 521711982 AMERICANS FOR MEDICAL PROGRESS EDUCATIONAL FOUNDATION AMER 2026248810 712 H ST NE PMB 98985 WASHINGTON DC 20002 PAULA CLIFFORD EXECUTIVE DIRECTOR 2026248810 2025-10-15 1 1 P01608821 4108840220 2024 2025-03-06 01:10:19Z PAULA CLIFFORD 712 H ST NE PMB 98985 WASHINGTON DC 20002 763819 0 X WWW.AMPROGRESS.ORG X 1991 VA SAFEGUARDING ANIMAL-BASED BIOMEDICAL RESEARCH THAT BENEFITS PEOPLE, ANIMALS & SOCIETY. 23 23 5 35 0 0 573338 606489 109705 142103 14 36 1827 -38279 684884 710349 7500 2500 0 0 492864 458632 0 0 18848 261793 233690 762157 694822 -77273 15527 191105 141929 92247 25278 98858 116651 X DEDICATED TO PROTECTING YOUR INVESTMENT IN BIOMEDICAL RESEARCH. WE FOCUS ON PUBLIC OUTREACH THAT BUILDS UNDERSTANDING AND APPRECIATION FOR NECESSARY AND HUMANE ANIMAL RESEARCH. WE ALSO PROVIDE VITAL NEWS, INFORMATION AND ANALYSIS TO BIOMEDICAL RESEARCH STAKEHOLDERS TO ENSURE THEY HAVE THE RESOURCES THEY NEED TO DEFLECT CAMPAIGNS THAT THREATEN THE FUTURE OF MEDICAL PROGRESS. 0 1 194320 2500 RAISING VOICES, SAVINGS LIVES - THE RAISING VOICES, SAVINGS LIVES (RVSL) CAMPAIGN IGNITES AND NURTURES PUBLIC APPRECIATION FOR THE IMPORTANCE OF BIOMEDICAL RESEARCH IN SCIENTISTS' QUEST FOR TREATMENTS AND CURES FOR PEOPLE AND ANIMALS. THIS INCLUDES DEVELOPMENT OF INNOVATIVE ADVOCACY RESOURCES THAT REACH NEW AUDIENCES VIA THEIR WEBSITE AND SOCIAL MEDIA, DVDS, POSTERS, PRESENTATIONS, AND EXHIBITS ILLUSTRATING THE ROLE OF ANIMAL MODELS IN RESEARCH. 140983 INFORMATION SERVICES - A PROGRAM THAT INCLUDES SPECIALIZED NEWSLETTERS, EMAIL ALERTS, AND OTHER SOURCES DESIGNED TO EQUIP THE BIOMEDICAL RESEARCH COMMUNITY WITH IMPORTANT NEWS, ACCURATE ANALYSIS OF CURRENT THREATS TO RESEARCH, AND UP-TO-THE-MOMENT ISSUE AWARENESS. THE UPDATES AND SECURITY ADVISORIES, PRESENTATIONS, MEDIA TRAINING, AND INDIVIDUAL CONSULTATIONS OFFER STAKEHOLDERS VITAL INFORMATION TO ENSURE CONTINUED MEDICAL PROGRESS. 126161 116184 BIOMEDICAL RESEARCH AWARENESS DAY (BRAD) - BEGAN AS A HAYRE FELLOWSHIP PROJECT AND IS NOW A PROGRAM UNDER RVSL. IT WAS LAUNCHED IN 2016 TO HONOR THE ROLES OF LABORATORY ANIMALS IN THE QUEST FOR NEW TREATMENTS AND CURES. BRAD IS HOSTED BY UNIVERSITIES, MEDICAL AND VETERINARY SCHOOLS, RESEARCH INSTITUTIONS, AND OTHERS. 35463 25919 CURIOUSSCIENCEWRITERS (CSW) - A LEARNING PROGRAM FOR HIGH SCHOOL STUDENTS WITH A PASSION FOR RESEARCH AND SCIENCE WRITING. LAUNCHED TO "ADVANCE THE ART OF SCIENCE COMMUNICATION," CSW IS AN INNOVATIVE, EXTRACURRICULAR ACTIVITY THAT TRAINS CREATIVE STUDENTS TO TRANSLATE COMPLEX BIOSCIENCE AND ENGAGE THE GENERAL PUBLIC THROUGH THE POWER OF STORY. 35463 25919 496927 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 13 0 1 5 1 0 0 0 0 0 0 0 0 0 0 0 0 X 23 23 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 0 0 AL AK AR CA CO CT FL GA HI IL KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND NV OR OK OH PA RI SC TN UT VA WA WV WI X PAULA CLIFFORD 2026248810 712 H ST NE PMB 98985 WASHINGTON DC 20002 GINA WILKERSON DVM CHAIR 1.00 X X 0 0 0 BILL YATES PHD TREASURER 1.00 X X 0 0 0 KHARY ADAMS MBA MLAS DIRECTOR 1.00 X 0 0 0 HARUT AVSAROGLU DVM PHD DIPL ECLAM DIRECTOR 1.00 X 0 0 0 CINDY BUCKMASTER PHD DIRECTOR 1.00 X 0 0 0 SHELLY CARBALLO DIRECTOR 1.00 X 0 0 0 LAURA A CONOUR DVM DACLAM DIRECTOR 1.00 X 0 0 0 MICHAEL T FALLON DVM PHD DIRECTOR 1.00 X 0 0 0 JOHN J FUNG MD PHD DIRECTOR 1.00 X 0 0 0 ALISSA HATFIELD MS DIRECTOR 1.00 X 0 0 0 RICHARD B HUNEKE DVM MPH DACLAM DIRECTOR 1.00 X 0 0 0 JOE KAYS DIRECTOR 1.00 X 0 0 0 J DAVID JENTSCH PHD DIRECTOR 1.00 X 0 0 0 TOM LEACH ESQ DIRECTOR 1.00 X 0 0 0 JENNIE LOFGREN DVM MS DACLAM DIRECTOR 1.00 X 0 0 0 AMY J LYONS DIRECTOR 1.00 X 0 0 0 LISA NEWBERN DIRECTOR 1.00 X 0 0 0 STACY PRITT DVM MS MBA CPIA CHRC DIRECTOR 1.00 X 0 0 0 AMY PUFFENBERGER MAM DIRECTOR 1.00 X 0 0 0 CHARLES ROSELLI PHD DIRECTOR 1.00 X 0 0 0 TANIA ROTH PHD DIRECTOR 1.00 X 0 0 0 RACHEL RUBINO DVM MS DACLAM DIRECTOR 1.00 X 0 0 0 ALLISON THIEDE DVM DACLAM DIRECTOR 1.00 X 0 0 0 PAULA CLIFFORD MLA RLATG CVT EXE. DIR. AND INTERIM SEC. AS OF OCT. 40.00 X 150383 0 13857 CARRIE LGIBSON COMMUNICATION & ADMIN MANAGER/SECRETARY UNTIL OCT. 40.00 X 63667 0 12680 214050 0 26537 1 0 1 0 0 606489 606489 BRAD REVENUE 900099 116184 116184 CURIOUS SCIENCE WRITER 900099 25919 25919 142103 36 36 14556 53470 -38914 -38914 MICELLANEOUS INCOME 561000 635 635 635 710349 142103 0 -38243 2500 2500 239494 178747 54884 5863 172048 128408 39428 4212 17227 12858 3947 422 29863 22841 6273 749 30120 30120 50925 33301 13624 4000 6936 919 5814 203 15606 10859 4391 356 9383 2157 7226 21433 18554 846 2033 4981 4981 460 343 106 11 7625 5832 1602 191 COMMUNICATIONS & OUTREA 48070 45904 2166 PRINTING 30590 28596 1994 DUES, SUBSCRIPTIONS, PU 3149 1505 1644 BAD DEBT 3000 3000 1412 603 1 808 694822 496927 179047 18848 99806 62672 274 269 65234 61137 846 633 824 4943 5413 4214 37371 36626 1205 745 7316 17503 0 191105 141929 77192 25278 15055 0 92247 25278 X -5552 24526 104410 92125 98858 116651 191105 141929 15527 2266 0 X X 0 1 X 1 0 X 551466 653592 580448 573338 606489 2965333 551466 653592 580448 573338 606489 2965333 867996 2097337 12 37 11 14 36 110 750 900 900 -2999 635 186 2965629 415069 0.70720 0.65390 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 12171 11426 745 25200 25200 0 745 INVESTMENT- CRYTOCURRENCY INVESTMENTS 7316 F 7316 X 766085 2266 53470 55736 710349 0 710349 748292 53470 53470 694822 0 694822 PART X, LINE 2: THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. PART XI, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 53,470. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 53,470. X 0 0 0 0 0 0 0 0 0 PAULA CLIFFORD MLA RLATG CVT EXE. DIR. AND INTERIM SEC. AS OF OCT 150383 0 0 0 0 0 11585 0 2272 0 164240 0 0 0 FORM 990, PART III, LINE 3 OTHER PROGRAMS - LAB RAT CHAT WAS A PODCAST DEDICATED TO PROVIDING THE PUBLIC WITH FACTUAL INFORMATION ABOUT THE IMPORTANCE OF HUMANE AND ETHICAL ANIMAL RESEARCH. IT WAS MADE POSSIBLE THROUGH THE MICHAEL D. HAYRE FELLOWSHIP IN PUBLIC OUTREACH. THIS PROGRAM ENDED IN 2023. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL HAVE AND MAY EXERCISE ALL THE POWERS AND AUTHORITY OF THE BOARD OF DIRECTORS IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF AMP AND MAY AUTHORIZE THE SEAL OF AMP TO BE AFFIXED TO ALL PAPERS THAT MAY REQUIRE IT. IN ADDITION, THE BOARD OF DIRECTORS MAY DELEGATE TO THE EXECUTIVE COMMITTEE POWER AND AUTHORITY TO ELECT ONE OR MORE OFFICERS OF AMP INCLUDING, WITHOUT LIMITATION, ITS EXECUTIVE DIRECTOR. NOTWITHSTANDING ANYTHING IN THE FOREGOING THAT MAY BE VIEWED TO THE CONTRARY, THE BOARD OF DIRECTORS SHALL HAVE AND RETAIN THE AUTHORITY TO REVIEW, AND TO TAKE ANY ACTION THE BOARD DEEMS ADVISABLE WITH RESPECT TO, ANY ACTION OF THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS FIRST REVIEWED BY THE EXECUTIVE DIRECTOR AND THE BOARD SECRETARY. THE 990 IS THEN REVIEWED BY THE AUDIT COMMITTEE BEFORE IT IS FINALIZED AND FILED WITH THE IRS. THE ENTIRE BOARD OF DIRECTORS RECEIVES AN ELECTRONIC COPY OF THE FORM 990 AFTER IT HAS BEEN FILED. FORM 990, PART VI, SECTION B, LINE 12C THE AMP CONFLICT POLICY IS SIGNED AND FILED ANNUALLY BY ALL BOARD MEMBERS, STAFF MEMBERS AND KEY STAKEHOLDERS UPON COMMENCEMENT OF THEIR RELATIONSHIP WITH AMP. THE POLICY STATES IT IS THE RESPONSIBILITY OF AN INDIVIDUAL TO FILE AN AMENDED VERSION OF THE FORM WITHIN 30 DAYS OF THE DEVELOPMENT OF A POTENTIAL CONFLICT OF INTEREST. THE POLICY AND FORM ARE DISTRIBUTED WITH THE MATERIALS FOR THE BOARD'S ANNUAL MEETING EACH YEAR. AMP IS INSTITUTING AN EMAIL OR OTHER REMINDER OF THE POLICY PROVISIONS EVERY 6 MONTHS TO ALL BOARD AND STAFF MEMBERS. THE POLICY ITSELF DETAILS THE ENFORCEMENT PROCEDURES: WHEN A POSSIBLE CONFLICT OF INTEREST IS DISCLOSED, THE BOARD OF DIRECTORS SHALL DETERMINE IF A CONFLICT OF INTEREST EXISTS, SHALL VOTE TO AUTHORIZE OR REJECT THE TRANSACTION OR TAKE OTHER ACTION DEEMED NECESSARY. THE BOARD MAY DELEGATE APPROVAL AUTHORITY UNDER THIS POLICY TO THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION FOR THE EXECUTIVE DIRECTOR IS DETERMINED BY THE BOARD OF DIRECTORS BASED ON COMPARABLE SALARIES AT THE TIME OF HIRING. ONGOING SALARY INCREASE DETERMINATIONS ARE MADE BASED ON THE EXECUTIVE DIRECTOR'S PERFORMANCE AND ANNUAL BUDGET OF THE ORGANIZATION. THE BOARD SECRETARY IS AN EMPLOYEE, THEREFORE THE EXECUTIVE DIRECTOR DETERMINES THE BOARD SECRETARY'S SALARY BASED ON OTHER JOB DUTIES. AN ANNUAL PERFORMANCE EVALUATION OF THE BOARD SECRETARY IS CONDUCTED. SALARY INCREASES ARE BASED ON PERFORMANCE AND AVAILABLE FUNDS IN THE APPROVED ANNUAL BUDGET OF THE ORGANIZATION. A PERFORMANCE EVALUATION OF THE EXECUTIVE DIRECTOR AND BOARD SECRETARY WERE LAST PERFORMED IN SEPTEMBER 2023. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON THE ORGANIZATION'S WEBSITE. PART XII, LINE 2C THE ORGANIZATION HAS NOT CHANGED ITS AUDIT OVERSIGHT PROCESS OR SELECTION PROCESS OF AN INDEPENDENT ACCOUNTANT DURING THE TAX YEAR.